Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX)

CUSIP: 74365A309

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
80,165,500
Total 13F shares
8,974,519
Share change
+6,036,881
Total reported value
$17,902,094
Put/Call ratio
19%
Price per share
$2.00
Number of holders
66
Value change
+$11,998,091
Number of buys
54
Number of sells
13

Quarterly Holders Quick Answers

What is CUSIP 74365A309?
CUSIP 74365A309 identifies PLX - Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) as of Q2 2023

As of 30 Jun 2023, Protalix BioTherapeutics, Inc. - Common Stock, $0.001 par value per share (PLX) was held by 66 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,974,519 shares. The largest 10 holders included BlackRock Inc., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, MARSHALL WACE, LLP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, NATIONAL BANK OF CANADA /FI/, JANE STREET GROUP, LLC, Nuveen Asset Management, LLC, and VANGUARD GROUP INC. This page lists 66 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.